ARALEZ PHARMACEUTICALS INC. Business Combination, Contingent Consideration, Liability, Noncurrent
ARALEZ PHARMACEUTICALS INC. had Business Combination, Contingent Consideration, Liability, Noncurrent of $90.78 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2018-05-08
- 2018-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $90.78M.
- 2017-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $88.87M.
- 2017-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $70.56M.
- 2017-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $65.81M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2018-03-31 | $90.78M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $88.87M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $70.56M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $65.81M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $65.17M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $60.69M 10-K · filed 2018-03-14 |
| 2016-09-30 | $18.90M 10-Q · filed 2016-11-08 |